XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses:        
Research and development $ 2,560 $ 11,715 $ 18,509 $ 38,769
General and administrative 10,105 8,560 26,498 26,037
Total operating expenses 12,665 20,275 45,007 64,806
Loss from operations (12,665) (20,275) (45,007) (64,806)
Interest income 448 351 1,317 871
Interest expense 0 (263) (284) (649)
Other income, net 596 617 2,043 357
Loss before income taxes (11,621) (19,570) (41,931) (64,227)
Income tax 7 23 (22) 9
Net loss $ (11,614) $ (19,547) $ (41,953) $ (64,218)
Net loss per share attributable to common stockholders-basic $ (0.31) $ (0.55) $ (1.17) $ (1.83)
Net loss per share attributable to common stockholders-diluted $ (0.31) $ (0.55) $ (1.17) $ (1.83)
Weighted-average shares of common stock outstanding-basic 36,922,236 35,247,680 36,005,269 35,013,189
Weighted-average shares of common stock outstanding-diluted 36,922,236 35,247,680 36,005,269 35,013,189